KIMBERLY CHITWOOD: Open Payments
NPI 1538585450 · COVINGTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 44 payments from 19 companies in 2025. Trend: 2023 $579 · 2024 $954 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $121 |
| PFIZER INC. | 5 | $115 |
| Lilly USA, LLC | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| SANOFI-AVENTIS U.S. LLC | 3 | $64 |
| Corcept Therapeutics | 2 | $41 |
| Astellas Pharma US Inc | 1 | $32 |
| Exact Sciences Corporation | 2 | $30 |
Products named: AIRSUPRA, MOUNJARO, ELIQUIS, Kerendia, TZIELD, SHINGRIX, Wegovy, Ozempic.
Industry payments across GA — which companies pay providers there.
